Briefing: Saudi Arabia Is Trying New Methods To Keep Selling Oil
Strategic angle: Exploring Saudi efforts to maintain oil sales amidst the rise of electric vehicles.
Editorial Staff Mar 9
All Articles
Browse the full archive, newest first.
Briefing: Landmark trial begins for Turkish opposition leader Imamoglu
Strategic angle: Istanbul's jailed mayor Ekrem Imamoglu faces a corruption trial seen as a political maneuver against him.
Editorial Staff Mar 9
Briefing: An $8.21 Gas Price In LA Shows How Fast Fuel Costs Are Rising
Strategic angle: War jitters and California tax quirks push pump prices skyward in the Golden State, but not all stations are so expensive.
Editorial Staff Mar 9
Briefing: Camera captures first video of a red fox attacking a wolf pup
Strategic angle: Unprecedented footage reveals a red fox challenging the natural order by attacking a wolf pup in Italy.
Editorial Staff Mar 9
Briefing: TSA Staff Shortages Cause Long Security Lines at Airports
Strategic angle: Travelers are facing hourslong waits at some airport security lines amid TSA staffing shortages.
Editorial Staff Mar 9
Briefing: How Dassault Systèmes AI companions redefine industrial design and manufacturing
Strategic angle: Euronews Next sat down with Florence Verzelen, executive vice president at Dassault Systèmes.
Editorial Staff Mar 9
Briefing: Stock Market Today: Dow Dives As Oil Prices Surge On Iran War; Transport Stocks Knife Lower (Live Coverage)
Strategic angle: Stock Market Today: Dow Dives As Oil Prices Surge On Iran War; Transport Stocks Knife Lower (Live Coverage)
Editorial Staff Mar 9
Briefing: Jefferies claims Western Alliance made ‘false’ statements over First Brands
Strategic angle: Wall Street war of words escalates as heads of US investment bank hit out at Arizona-based lender
Editorial Staff Mar 9
Briefing: BlackRock Won’t Let Billionaires Cash Out of Its $26B Fund. That Should Worry Everyone.
Strategic angle: BlackRock's decision to restrict cashing out from its massive fund raises concerns about financial stability.
Editorial Staff Mar 9
Briefing: A setback for Roche’s breast cancer drug
Strategic angle: Wall Street's verdict on Prasad, generic semaglutide's new pricing, and other biotech news
Editorial Staff Mar 9